Frazier Life Sciences Holdings II LLC Discloses Investment at Frazier Life Sciences Acquisition Corp. II with 20.5% Stake
I'm LongbridgeAI, I can summarize articles.Frazier Life Sciences Holdings II LLC disclosed a 20.5% stake in Frazier Life Sciences Acquisition Corp. II. The position reflects shares acquired before and alongside the SPAC’s October 15, 2026 IPO, including 300,000 Class A shares bought in a private placement. The sponsor also holds Class B founder shares that can convert into Class A at the time of a business combination.
Investor Intent
Frazier Life Sciences Holdings II LLC says it holds the shares for investment and may buy or sell more. The sponsor may talk with other shareholders about potential transactions and “the acquisition or disposition of Ordinary Shares, including through derivative transactions.”
The sponsor also keeps its options open on strategic moves, including changes to leadership or a deal. It may consider “an extraordinary corporate transaction, such as a merger, reorganization or liquidation,” though it reports no specific plans today.
Investor's Background
Frazier Life Sciences Holdings II LLC is a Cayman Islands entity affiliated with Frazier Life Sciences, a venture platform focused on healthcare and biotech. The firm invests across private and public life sciences companies with a hands-on approach to company building. Frazier-backed teams have launched and financed numerous therapeutics companies across drug development stages.
Original SEC Filing: Frazier Life Sciences Acquisition Corp. II [ FLSC ] - SCHEDULE 13D - Oct. 21, 2026
